Identifying clinically questionable psychotropic prescribing practices for medicaid recipients in new york state.
about
Effectiveness of switching from antipsychotic polypharmacy to monotherapy.Use of Pooled State Administrative Data for Mental Health Services Research.A methodological protocol for selecting and quantifying low-value prescribing practices in routinely collected data: an Australian case study.Use of Psychotropic Medications among Youth in Treatment Foster Care.Disparities in quality of care among publicly insured adults with schizophrenia in four large U.S. states, 2002-2008Best Practices: MEDNET: a multistate policy maker-researcher collaboration to improve prescribing practicesMultilevel predictors of clinic adoption of state-supported trainings in children's servicesValidation of a claims-based antipsychotic polypharmacy measureTrends in psychotropic polypharmacy among youths enrolled in Ohio Medicaid, 2002-2008Antipsychotic treatment among youth in foster care.Where You Live Matters: Quality and Racial/Ethnic Disparities in Schizophrenia Care in Four State Medicaid Programs.Changes in antipsychotic use among patients with severe mental illness after a Food and Drug Administration advisoryThe role of parent characteristics in community-based medication treatment for children with disruptive behavior problems.Primary care providers' views on metabolic monitoring of outpatients taking antipsychotic medication.Prescription Drug Use and Polypharmacy Among Medicaid-Enrolled Adults with Autism: A Retrospective Cross-Sectional AnalysisThe Influence of Previous Antipsychotic Polypharmacy Versus Monotherapy on the Effectiveness of Antipsychotic after Switching to Paliperidone Extended-release.Statewide implementation of the 4 Rs and 2 Ss for strengthening families.Scaling up evidence-based practices for children and families in New York State: toward evidence-based policies on implementation for state mental health systems.Diabetes and Cardiovascular Care Among People with Severe Mental Illness: A Literature Review.Valproic Acid in Women and Girls of Childbearing Age.[Factors associated with high exposure to psychotropic drugs in a Montreal catchment epidemiological area].Diabetes Screening among Antipsychotic-Treated Adults with Severe Mental Illness in an Integrated Delivery System: A Retrospective Cohort Study.Using Survival Analysis to Understand Patterns of Sustainment within a System-Driven Implementation of Multiple Evidence-Based Practices for Children's Mental Health Services.
P2860
Q30542484-73540949-F4C2-4286-8648-75E8EB1F0777Q30884023-D958C828-530E-419A-8185-42058DEEF920Q33634843-096C4E19-C187-482B-A6C1-1F6DDC3F03A1Q33699936-D9AC3E16-6F6D-4FB4-A787-13867CD530F3Q33953271-B3F5F067-AD66-43E6-B06E-5564D51EABBAQ35379459-8592579A-5B9B-4109-A619-26661384DA3CQ35561713-CEEFC59F-6347-48A4-97B5-F2AA99A24417Q35801221-5AC2BBAE-E1F4-4210-873C-148B8CC5C00BQ35962531-6872FF08-7099-4431-A748-B999C654BA48Q36071218-D26B6A77-0055-4E4A-84E7-C23666A6AB49Q36144487-20DD23B6-7964-45F0-A3FA-BAB87CA343DFQ36201085-46CCE977-B23E-4AD3-A3C0-4A31ACBA189DQ36454422-62BFE022-C225-4D49-92E7-183B9618B6C9Q37191101-9EEC1753-104C-4E0E-BFF4-76295622311DQ37452761-BC83278F-AB4D-4946-9680-FCC93A5C92DDQ37500587-B336DB9A-60C5-49B9-BE10-9039A78A6D27Q37526507-D23E26A3-959B-4A9F-8A61-63C4C28EF422Q37638484-ADBE9FC8-E1CF-4A97-AE5E-790264E89257Q38826676-FE204BD9-21F8-45BD-84A4-E65671E0422BQ39446928-A6B4BAD1-6F2B-4873-977D-D345B554C52AQ43550125-52135D1B-3D12-4961-98E7-25FC6F704D94Q46642105-52292EAD-CD2C-4BB7-A759-A88E7380BA62Q52652946-53E5296F-3865-41F4-A7E9-73B23C4D6ECE
P2860
Identifying clinically questionable psychotropic prescribing practices for medicaid recipients in new york state.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Identifying clinically questio ...... recipients in new york state.
@en
Identifying clinically questio ...... recipients in new york state.
@nl
type
label
Identifying clinically questio ...... recipients in new york state.
@en
Identifying clinically questio ...... recipients in new york state.
@nl
prefLabel
Identifying clinically questio ...... recipients in new york state.
@en
Identifying clinically questio ...... recipients in new york state.
@nl
P2093
P1433
P1476
Identifying clinically questio ...... d recipients in new york state
@en
P2093
Edith Kealey
Emily Leckman-Westin
Jeffrey A Lieberman
Lloyd I Sederer
Nancy H Covell
Susan M Essock
P304
P356
10.1176/PS.2009.60.12.1595
P577
2009-12-01T00:00:00Z